AtriCure (ATRC) Net Cash Flow (2010 - 2026)

AtriCure (ATRC) has 17 years of Net Cash Flow data on file, last reported at -$21.1 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 8.38% year-over-year to -$21.1 million in Q1 2026; TTM through Mar 2026 was $45.9 million, a 30.97% increase from a year earlier, with the FY2025 full-year figure at $44.0 million, up 13.2% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$21.1 million, down from $19.5 million in the prior quarter.
• Over the last five years, Net Cash Flow for ATRC reached as high as $41.1 million in Q2 2024 and fell as low as -$23.0 million in Q1 2025.
• Historically, Net Cash Flow has averaged $6.0 million across 5 years, with a median of $9.0 million in 2022.
• On a YoY basis, Net Cash Flow climbed as much as 508.19% in 2024 and fell as far as 297.59% in 2024.
• Year by year, Net Cash Flow stood at $9.0 million in 2022, then tumbled by 60.1% to $3.6 million in 2023, then tumbled by 297.59% to -$7.1 million in 2024, then soared by 374.24% to $19.5 million in 2025, then slumped by 208.09% to -$21.1 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$21.1 million in Q1 2026, $19.5 million in Q4 2025, and $30.1 million in Q3 2025.